RomeoAngMandanasMDFACP

PubMed

• 13 citations
  Randomized Phase II Study of Cetuximab and Bevacizumab in Combination with Two Regimens of Paclitaxel and Carboplatin in Chemonaive Patients with Stage IIIB/IV Non–Sma...
  Philip Bonomi, Joseph Mace, Romeo A. Mandanas, Myo Min, Mark R. Olsen
  Journal of Thoracic Oncology. 2013-03-01
• 63 citations
  Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care.
  David J. Kuter, Susan D. Mathias, Mathias J. Rummel, Romeo A. Mandanas, Aristoteles Giagounidis
  American Journal of Hematology. 2012-05-01
• 127 citations
  Role of p21 RAS in p210 bcr-abl Transformation of Murine Myeloid Cells
  R. A. Mandanas, D. S. Leibowitz, Kamran Gharehbaghi, T Tauchi, Burgess Gs
  Blood. 1993-09-15

Journal Articles

• Bartter's Syndrome: successful treatment with indomethacin and potassium chloride.  
  Mandanas RA, Phil J Nephrol 1:62-66
• Autologous bone marrow transplantation for non-hodgkin's lymphoma: experience at Oklahoma Health Sciences Center 1984-1993.  
  Saez RA, Slease RB, Selby GB, Puckett C, Epstein RB, Mandanas RA, Confer DL, J Okla State Med Assoc 87:358-363
• Autologous bone marrow transplantation for metastatic breast cancer: experience at Oklahoma University Health Sciences Center 1983-1993.  
  Saez RA, Selby GB, Slease RB, Epstein RB, Mandanas RA, Confer DL, J Oklahoma State Med Assoc 87:405-410

Abstracts/Posters

• Virtual Hematopathology Web: Developing an educational resource for the World Wide Web.
  Mandanas RA, Blood 88(10) Suppl 1:158b (Abstr 3360)
• Formation of fibrin clots in cryopreserved stem cell bags during thawing procedure: lack of impact on engraftment.
  Mandanas RA, Kratochvil K, Garner T, Selby GB, Blood 90(10) Suppl 1:353b (Abstr 4336)
• G-CSF-mobilized donor leukocyte infusions as immunotherapy for acute leukemia in relapse after allogeneic bone marrow transplantation (BMT).
  Mandanas RA, Saez RA, Selby GB, Roy V, Confer DL, Blood 90(10) Suppl 1:382b (Abstr 4465)
• Randomized Comparison of two schedules for peripheral blood progenitor cell mobilization in high-risk breast cancer patients.
  31. Roy V, Mandanas RA, Carter TH, Selby GB, Blood 1999:94(10) Suppl 1; 371b Abstr# 1459
• Successful non-surgical treatment of disseminated polymicrobial fungal infection of lungs and brain in a patient with pancytopenia and GVHD.
  Roy V, Ali LI, Mandanas RA, Carter TH, Selby GB, Blood 1999:94(10) Suppl 1; 371b Abstr# 4887
• Electrogastrographic changes in patients after allogeneic stem cell transplantation.
  Mandanas RA, Lin XM, Chen JZ, ASBMT Meeting, Abstr #74
• High nucleated cell concentration at freezing does not affect thawing of peripheral blood stem cells and clinical engraftment outcome of autologous transplants.
  Mandanas RA, Watkins CL, Geister BV, Smith JW, ISHAGE 2000 Meeting, San Diego, CA
• High-dose Carmustine, Etoposide, Cytarabine, Cyclophosphamide (BEAC) is feasible in an outpatient community setting for patients (Pts) with relapsed AND and high-risk ...
  Alan Kritz, Romeo Mandanas, Luceli Cuasay, Kimberly Quiett, Lori Williams, Roy Beveridge, Gary Spitzer, Robert Rifkin, US Oncology Transplant Network. Blood 96(11):Abstr 5357
• Autologous stem cell transplants (ASCT) for Multiple Myeloma (MM) in a network of community-based transplant programs.
  Romeo Mandanas, Alan Kritz, Luceli Cuasay, Kimberly Quiett, Lori Williams, Roy Beveridge, Gary Spitzer, Robert Rifkin, US Oncology Transplant Network. Blood 96(11):Abstr 5362
• Open-Label Randomized Comparison of Dolasetron versus Ondansetron for Prevention of Nausea and Vomiting During High-Dose Chemotherapy and Stem Cell Transplantation.
  R. Mandanas, R. Beveridge, R. Rifkin, H. Wallace, A. Greenspan, G. Spitzer, H Guo, L, Asmar. BBMT 2004:10:Suppl 1:87
• Pegfilgrastim following chemotherapy leads to successful mobilization of hematopoietic progenitor cells among transplant patients with various diagnoses.
  RA Mandanas, B Underwood, BV Geister, JW Smith, ASBMT in Orlando Florida. BBMT 2004:10: Suppl 1:14
• Myeloablative related-donor allogeneic stem cell transplants (AlloMSCT) are feasible and can be performed safely in the totally outpatient ambulatory setting.
  RA Mandanas, BV Geister, BJ Underwood, ASBMT in Orlando Florida. BBMT 2004:10:Suppl 1:40
• Phase II Trial of GM-CSF as maintenance Therapy Post-Autologous Peripheral Blood Stem Cell Transplant in Multiple Myeloma.
  Mandanas RA, Beveridge R, Rifkin R, Greenspans AR, Orloff GJ, Klein L, matous JV, Rauch MA, Boehm KA, Zhan F, Asmar L, BBMT 2005:11(2) Suppl 1:75
• Results of a randomized phase II trial of pegfilgrastim versus filgrastim to treat Neutropenia post-autologous peripheral blood stem cell tansplant (PBSCT) with Non-Ho...
  Rifkin R, Beveridge R, Spitzer G, Orloff G, Mandanas RA, McGaughey D, Zhan F, Boehm AK, Asmar L, Beveridge R, Blood:110(11): Abstract 4936
• Pegfilgrastim (P) Appears to be Equivalent to Multiple Daily Doses of Filgrastim (F) to Treat Neutropenia Post-Autologous Peripheral Blood Stem Cell Transplant (PBSCT)...
  Rifkin R, Beveridge R, Spitzer G, Orloff G, Mandanas R, McGaughey D, Zhan F, Boehm K, Asmar L, BBMT:14(2) Suppl 1:31-32
• Results of a phase II open-label trial of bortezomib in patients with multiple myeloma who have undergone high-dose melphalan therapy followed by autologous peripheral...
  Rifkin RM, Spitzer G, Greenspan A, Schwerkoske JF, Brunvand MW, Mandanas RA, Stephenson JJ, Zhan F, Asmar L, Beveridge R, Blood:112(11): Abstract 2780
• Phase 2 Randomized, Open-Label Study of Cetuximab (Cet) and Bevacizumab (Bev) in Combination with Paclitaxel (P) and Carboplatin © in Patients (pts) with Stage III/IV ...
  Bonomi P, Mace J, Mandanas R, Min M, Zhang Y, Rowinsky E, Youssoufian H, J Clin Oncol:27(15S): Abstract 8046
• Home Administration of Romiplostim by Patients with Chronic Immune Thrombocytopenia (ITP).
  Lyons R, Boccia R, Macik G, Mandanas R, Wang X, Lizambri R, Berger D, Blood:114(22) 1362 – Abstract 3510
• Patient Quality of Life in Nonsplenectomized Immune Thrombocytopenia (ITP) Patients Receiving Romiplostim or Medical Standard of Care.
  Rummel M, Kuter D, Mandanas R, Giagounidis A, Coughlin P, Wang X, Mathias SD, Deuson R, Blood:116(21) – Abstract 569
• Use of Rituximab in a Study Comparing the Thrombopoietin Mimetic Romiplostim with Standard of Care (SOC) in Patients with Immune Thrmbocytopenia (ITP).
  Wasser J, Boccia RV, Lyons RM, Mandanas R, Pabinger I, Michel IV M,Viallard J-F, Wang X, Lizambri R, Blood:118(21) 1411 – Abstract 3282
• Infectious complications following bone marrow transplantation in autologous vs. allogeneic marrow recipients.
  Mandanas RA, ACP Regional Meeting Abstract Book
• Chronic Myelomonocytic Leukemia presenting as cutaneous vasculitis.
  Tsai YH, Mandanas RA, Arnold E, ACP Regional Meeting Abstract Book
• Thrombotic thrombocytopenic purpura in an allogeneic bone marrow transplant patient.
  Tsai YH, Mandanas RA, Karanes C, ACP Regional Meeting Abstract Book
• BCR/ABL confers growth factor independence upon a murine myeloid cell line.
  Mandanas R, Boswell HS, Bruno E, Hoffman R, Leibowitz D, Clin Research 39(2):338A, AFCR National Meeting Seattle, WA
• Transformation of myeloid cell line by BCR/ABL involves constitutive expression of c-jun and c-fos.
  Mandanas R, Boswell HS, Leibowitz D, Blood 78(10) Suppl 1:330a Abstr 1311, ASH 33rd annual meeting Denver, CO
• Join now to see all

Lectures

• Recent Therapies in Acute Myeloid Leukemia. 
• Non-myeloablative Mini-Allotransplantation. 
  Deaconess CME Program
• Five Cancers of Importance. 
  Shawnee Hospital
• High-Dose chemotherapy and Autologous Peripheral Blood Stem Cell Tansplantation, Where Do We Stand? 
  Mercy Hospital CME Didactic Presentation
• Hematopoietic Stem Cell Transplantation. 
  Integris Baptist Department of Internal Medicine
• Immunochemotherapy in Relapsed Acute Myeloid Leukemia. 
  Halifax Medical Center, Daytona Beach Florida
• Anemia in Patients with Cancer. 
  Deaconess CME Program, Anemia in Cancer Patients, Oklahoma City, OK
• Targeted Therapies in Clinical Oncology. 
  Integris Baptist Cancer Conference
• Infectious Complications following bone marrow transplantation in autologus vs. allogeneic marrow recipients. 
  American College of Physicians Regional Meeting, Traverse City, MI
• BCR/ABL confers growth factor independence upon a murine myeloid cell line. 
  American Federation For Clinical Research Meeting, Seattle, WA
• Constitutive expression of nuclear protooncogenes C-myc, C-jun, and C-fos in p210BCR/ABL transformation of myeloid cell line to IL-3 independence. 
  American Federation for Clinical Research Midwest Meeting, Chicago, IL
• Chronic Myelogenous Leukemia. 
  Department of Medicine Hematology/Oncology Resident-Student Conferences
• Bone Marrow Transplant Donor Selection and Transplant-related Complications - a presentation of 3 cases. 
• Immunotherapy with Histocompatible Donor Leukocytes. 
  Hematology/Oncology Conference
• Cytomegalovirus Surveillance and Prevention in Allogeneic BMT Recipients. 
  Monthly Medicine Research Seminar
• High Dose Chemotherapy and Autologous Bone Marrow Transplants in Testicular Cancer. 
  Monthly Urology Conference
• Relapse after BMT for leukemia: Options for treatment. 
  BMT Support Group Lecture
• BMT support groups on the Internet. 
  BMT Support Group Lecture
• Outpatient Stem Cell Transplants. 
  BMT Support Group
• Virtual Hematopathology: A WWW Resource. 
  Wednesday Hem-Onc conference
• New Developments in BMT for Germ Cell Cancer. 
  Monthly Urology Conference
• The Importance of Bone Marrow Donors. 
  Oklahoma Blood Institute Special Celebration for BM Donors
• Gastroenterology Conference. 
  Graft-versus-Host Disease
• Multiple Myeloma. 
  Lecture to Medicine Residents
• Cytomegalovirus Infection: An Approach to Management in Allogenic BMT. 
  Hem-Onc conference
• Join now to see all

Other

• Fungal Pneumonia. 
  Mandanas, RA, EMedicine from WebMD
  http://www.emedicine.com/med/topic1853.htm
• Graft Versus Host disease. 
  Mandanas, RA, EMedicine from WebMD
  http://www.emedicine.com/MED/topic926.htm